As the Indian stock market braces for a series of Initial Public Offerings (IPOs) in December 2024, investors are keenly watching the Grey Market Premium (GMP) for insights into potential gains. The GMP is an unofficial market trend that provides early indicators of the listing price compared to the IPO price. In this article, we will cover the upcoming IPOs, their GMP trends, estimated listing gains, and key details to help you make informed investment decisions.
1. Rosmerta Digital Services IPO
The Rosmerta Digital Services IPO, set to open on December 10, 2024, offers shares in the price band of ₹147. The GMP for this IPO is ₹22, indicating an estimated listing price of ₹169. This results in a 14.97% premium over the issue price. With an IPO size of ₹206.33 Cr and a lot size of 1000 shares, the IPO has garnered a 3/5 rating. Given its consistent demand in the Grey Market, investors may find this IPO attractive for short-term investments.
Also Read: IPO GMP
2. International Gemmological Institute IPO
The International Gemmological Institute IPO, slated for launch on December 13, 2024, has a strong GMP of ₹145, which translates to an estimated listing price of ₹562—a remarkable 34.77% premium over the issue price of ₹417. The IPO size stands at a significant ₹4225.00 Cr, with a lot size of 35 shares. Rated 4/5, this IPO is expected to generate substantial investor interest due to the strong premium and the company’s established position in the industry.
3. Inventurus Knowledge Solutions IPO
Opening on December 12, 2024, the Inventurus Knowledge Solutions IPO offers shares at ₹1329. The GMP for this IPO is currently ₹350, suggesting an estimated listing price of ₹1679—a solid 26.34% premium. With an IPO size of ₹2497.92 Cr and a lot size of 11 shares, this IPO is rated 4/5 and is expected to provide significant returns for investors, especially given its strong financials and market potential.
4. Yash Highvoltage BSE SME IPO
Yash Highvoltage’s IPO, expected to open on December 12, 2024, is priced in the range of ₹NA, with a GMP of ₹50. While the estimated listing price has not yet been finalized, the ₹50 GMP suggests a modest potential premium. The IPO size is ₹109.50 Cr, and the lot size is 1000 shares. With no rating yet assigned, this IPO might still be of interest to investors looking for a speculative opportunity.
5. Mobikwik IPO
The much-awaited Mobikwik IPO is expected to open on December 11, 2024, with a price band of ₹279. The GMP for this IPO is ₹130, translating to an estimated listing price of ₹409, marking a 46.59% premium. With a market size of ₹572.00 Cr and a lot size of 53 shares, this IPO has earned a 4/5 rating, making it one of the most anticipated IPOs of December 2024.
6. Sai Life Sciences IPO
Sai Life Sciences is set to open its IPO on December 11, 2024, with a price band of ₹549. The GMP stands at ₹28, indicating an estimated listing price of ₹577, a 5.10% premium. With an IPO size of ₹3042.62 Cr and a lot size of 27 shares, this IPO has a 2/5 rating, and although it offers lower returns compared to other IPOs, it may still appeal to long-term investors.
7. Vishal Mega Mart IPO
The Vishal Mega Mart IPO, scheduled to open on December 11, 2024, comes with a price band of ₹78 and a GMP of ₹25, implying an estimated listing price of ₹103—a 32.05% premium. The IPO size is ₹8000.00 Cr, with a lot size of 190 shares, and it has received a 4/5 rating. With its established brand in the retail sector, this IPO is likely to attract significant investor attention.
8. Supreme Facility Management NSE SME IPO
The Supreme Facility Management NSE SME IPO, opening on December 11, 2024, is priced at ₹76 per share, with a GMP of ₹0, suggesting no immediate premium. The IPO size is ₹50.00 Cr, and the lot size is 1600 shares. With a 1/5 rating, this IPO may be less appealing for short-term investors, although long-term growth potential remains uncertain.
9. Purple United Sales NSE SME IPO
Set to open on December 11, 2024, the Purple United Sales IPO is priced at ₹126, with a GMP of ₹20, suggesting an estimated listing price of ₹146—a 15.87% premium. The IPO size is ₹32.81 Cr, with a lot size of 1000 shares. Rated 3/5, this IPO provides moderate returns and may be suited for investors with a balanced risk appetite.
Conclusion
As of December 10, 2024, December is shaping up to be an exciting month for IPO investors, with a wide range of IPOs offering varying levels of GMP premiums. From the highly anticipated Mobikwik IPO with an expected 46.59% premium to the more moderate offerings like Rosmerta Digital Services IPO and Sai Life Sciences IPO, investors have a plethora of options to consider based on their investment goals and risk tolerance.
As always, investors should conduct thorough research and consult financial advisors before making any investment decisions. The IPO market is volatile, and while GMP trends can provide early indicators, they are not always definitive of long-term returns. Stay tuned for more updates as these IPOs approach their launch dates.